managing. So, it is our responsibility as an
ophthalmologist, and also local governments to
continuously strive to improve the facilities and
human resources in our province, in order to perform
good management for our patients later.
REFERENCES
American Academy of Ophthalmology staff., (2014-
2015). Other Retinal Vascular Diseases. In: American
Academy of Ophthalmology staff, ed. Retina and
Vitreous. Basic and Clinical Science Course. Sec 12.
Sanfransisco: American Academy of Ophthalmology.
pp. 113-55
Banaei, N., Gaur, RL., Pai, M., (2016). Interferon Gamma
Release Assays for Latent Tuberculosis: What are the
Sources of Variability? Journal of Clinical
Microbiology. 54, 845-850.
Biswas, J., Sharma, T., Gopal, L., Madhavan, HN.,
Sulochana, KN., Ramakrishnan, S., (2002). Eales
disease—an update. Survey of ophthalmology. 47(3),
197-214.
Biswas, J., Verma, A., (2007). An Update on Eales’
Disease. Kerala Journal of Ophthalmology. 19, 300-
307
Dalvin, LA., Smith, WM., (2017). Intraocular
manifestations of mycobacterium tuberculosis: A
review of the literature. Journal of Clinical
Tuberculosis and Other Mycobacterial Diseases. 7,
13-21.
Das, T., Biswas, J., Kumar, A., Nagpal, PN.,
Namperumalsamy, P., Patnaik, B., Tewari, HK.,
(1994) Eales' disease. Indian J Ophthalmol. 43, 3-18.
Das, T., Pathengay, A., Hussain, N., Biswas, J., (2010).
Eales’ disease: diagnosis and management. Eye. 24
(3), 472.
Do, BK., Giovinazzo, J., (2016). Retinal Vasculitis. Adv
Ophthalmol Optom.1(1), 69–84.
Gadkari, S., (2007) Inflamatory vascular disease. Eales’
disease. In: Joussen, AM., Gardner, TW., Kirchhof,
B., Ryan, SJ, ed. Retina Vascular Disease. Berlin:
Springer.p.613-627
Katyal, M., Leibowitz, R., Venters, H., (2018). IGRA-
Based Screening for Latent Tuberculosis Infection in
Persons Newly Incarcerated in New York City Jails.
Journal of Correctional Health Care. 24(2),156-170.
Ku, JH., Ali, A., Suhler, EB., Choi, D., Rosenbaum, JT.,
(2012). Characteristics and visual outcome of patients
with retinal vasculitis. Arch Ophthalmol.
130(10),1261–1266.
Mesquida, M., Llorens, V., Adán, A., (2017). New
imaging techniques in retinal vasculitis. Med Clin
(Barc) 149(6), 261–6.
Mir,TA., Reddy, AK., Burkholder, BM., Walsh, J.,
Shifera, AS., Khan, IR., Thorne, JE., (2017). Clinical
Features and Incidence Rates of Ocular Complications
in Patients With Retinal Vasculitis. Am J Ophthalmol
179,171–178.
Murugeswari, P., Shukla, D., Kim, R., Namperumalsamy,
P., Stitt, AW., Muthukkaruppan, V., (2014).
Angiogenis Potential of Vitreous from Proiferative
Diabetic Retinopathy and Eales’ Disease Patients.
PloS ONE. 9(10), 1-8.
Patnaik, B., Nagpal, PN., Namperumalsamy, P., Kalsi, R.,
(1998). Eales disease: clinical features,
pathophysiology, etiopathogenesis. Ophthalmology
Clinics. 11(4), 601-617.
Pelegrin, L., Hernández-Rodríguez, J., Espinosa, G.,
Llorenç, V., Sainz-de-la-Maza, M., Fontenla, JR.,
(2017). Characterization of isolated retinal vasculitis.
Analysis of a cohort from a single center and literature
review. Autoimmun Rev. 16(3), 237–243.
Sharief, L., Lightman, SUE., Blum-hareuveni, T., Bar, A.,
Tomkins-netzer, O., (2017). Clinical Outcome of
Retinal Vasculitis and Predictors for Prognosis of
Ischemic Retinal Vasculitis. Am J Ophthalmol 177,
206–212.
Talat, L., Lightman, S., Tomkins-Netzer, O., (2014).
Ischemic Retinal Vasculitis and its Management.
Journal of Ophthalmology. 7, 1-13